![Genprex Inc](/common/images/company/N_GNPX.png)
Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex's technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who cur... Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex's technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Genprex's oncology program utilizes its systemic, non-viral Oncoprex® Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The resultant product is administered intravenously, where it is taken up by tumor cells that then express tumor suppressor proteins that were deficient in the tumor. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0699 | -13.98 | 0.5 | 0.57 | 0.37 | 4674851 | 0.46937661 | CS |
4 | -0.2903 | -40.2970571904 | 0.7204 | 0.7636 | 0.37 | 1211803 | 0.48660184 | CS |
12 | -0.6299 | -59.4245283019 | 1.06 | 1.26 | 0.37 | 843925 | 0.74237215 | CS |
26 | -0.1985 | -31.5781100859 | 0.6286 | 3.961 | 0.2806 | 5194239 | 2.1196068 | CS |
52 | -4.1899 | -90.6904761905 | 4.62 | 5.41 | 0.2806 | 2664072 | 2.11778777 | CS |
156 | -87.5699 | -99.51125 | 88 | 106.8 | 0.2806 | 1129110 | 10.39595752 | CS |
260 | -183.5699 | -99.76625 | 184 | 308.8 | 0.2806 | 1512619 | 84.4039766 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約